West Pharmaceutical
295 hedge funds and large institutions have $5.44B invested in West Pharmaceutical in 2017 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 114 increasing their positions, 98 reducing their positions, and 31 closing their positions.
52% more call options, than puts
Call options by funds: $351K | Put options by funds: $231K
42% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 31
16% more repeat investments, than reductions
Existing positions increased: 114 | Existing positions reduced: 98
2% more funds holding
Funds holding: 288 → 295 (+7)
0.74% less ownership
Funds ownership: 91.68% → 90.94% (-0.74%)
4% less capital invested
Capital invested by funds: $5.69B → $5.44B (-$248M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$480M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$32.8M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$22M |
| 4 |
Select Equity Group
New York
|
+$16M |
| 5 |
JP Morgan Chase
New York
|
+$15.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KI
Kalmar Investments
Greenville,
Delaware
|
-$48.3M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$43.1M |
| 3 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$26.7M |
| 4 |
RCG
Ruane, Cunniff & Goldfarb
New York
|
-$26.3M |
| 5 |
BAMCO Inc
New York
|
-$19.9M |
WST Hedge Fund Activity: Q1 2017 in Review
295 of the 4,034 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q1 2017, worth a combined $5.44B — down 4.4% from $5.69B a quarter earlier.
Buyers outnumbered sellers: 44 funds opened new WST positions and 31 closed out — a net gain of 13 holders — while 114 added to existing stakes and 98 trimmed.
The largest buyer was BlackRock, adding an estimated $480M. The largest seller was Kalmar Investments, cutting an estimated $48.3M.
- 295 institutional investors held West Pharmaceutical (WST) as of Q1 2017, up from 288 in Q4 2016.
- Funds reported $5.44B of West Pharmaceutical stock for Q1 2017, down 4.4% quarter-over-quarter.
- 44 funds opened new West Pharmaceutical positions in Q1 2017 and 31 closed out, a net change of +13 holders.
- The largest West Pharmaceutical buyer in Q1 2017 was BlackRock, an estimated $480M added.
- The largest West Pharmaceutical seller in Q1 2017 was Kalmar Investments, an estimated $48.3M sold.
Based on aggregated 13F filings for Q1 2017.